{
  "Q0": "BRCA1 and BRCA2 (hereditary breast and ovarian cancer) gene analysis; full sequence analysis and full duplication/deletion analysis (BRCA testing).",
  "Q1": "Yes",
  "Q2": "Yes",
  "Q3": "Yes",
  "Q4": "Yes",
  "Q4a": "Yes",
  "Q4b": [
    "NCCN"
  ],
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes",
  "Q9a": "Yes",
  "Q10": "No",
  "Q10a": "Risk Assessment",
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Yes",
  "Q14": "Yes",
  "Q14a": [
    "81162",
    "81163",
    "81164",
    "81212",
    "81215",
    "81216",
    "81217"
  ],
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "The following steps must be followed under the policy to submit the claim: The provider must complete the 'Aetna Breast and Ovarian Cancer Susceptibility Gene Testing Prior Authorization Form' and submit it along with the laboratory's test requisition form to Aetna for precertification. Documentation of the patient's cancer diagnosis and pertinent medical records, including a summary of how the test will impact immediate medical care, should be included. The laboratory should not perform the test until confirmation of coverage and precertification is received from Aetna. Genetic counseling should be provided prior to testing. Both the laboratory and Aetna will confirm member eligibility before testing is performed.",
  "match": true
}